MOESM4 of AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models

Additional file 4: Figure S4. Binding of mouse anti-Gal antibodies and complement deposition on AGI-134-treated mouse melanoma cells. (A–D) B16-F10 or JB/RH cells were treated with the indicated AGI-134 concentrations or the negative control glycolipid FSL-A. The cells were then incubated with mouse...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Shaw, Stephen, Middleton, Jenny, Wigglesworth, Kim, Charlemagne, Amber, Schulz, Oliver, Glossop, Melanie, Whalen, Giles, Old, Robert, Westby, Mike, Pickford, Chris, Tabakman, Rinat, Carmi-Levy, Irit, Abi Vainstein, Sorani, Ella, Zur, Arik, Kristian, Sascha
Format:	Video
Sprache:	eng
Schlagworte:	Biochemistry Cancer Cell Biology Developmental Biology Ecology Evolutionary Biology FOS: Biological sciences FOS: Clinical medicine Genetics Immunology Molecular Biology
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!